1. Home
  2. NVRI vs STOK Comparison

NVRI vs STOK Comparison

Compare NVRI & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVRI
  • STOK
  • Stock Information
  • Founded
  • NVRI 1853
  • STOK 2014
  • Country
  • NVRI United States
  • STOK United States
  • Employees
  • NVRI N/A
  • STOK N/A
  • Industry
  • NVRI Diversified Commercial Services
  • STOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • NVRI Miscellaneous
  • STOK Health Care
  • Exchange
  • NVRI Nasdaq
  • STOK Nasdaq
  • Market Cap
  • NVRI 673.0M
  • STOK 638.8M
  • IPO Year
  • NVRI N/A
  • STOK 2019
  • Fundamental
  • Price
  • NVRI $8.66
  • STOK $11.43
  • Analyst Decision
  • NVRI Hold
  • STOK Strong Buy
  • Analyst Count
  • NVRI 1
  • STOK 5
  • Target Price
  • NVRI $10.00
  • STOK $24.50
  • AVG Volume (30 Days)
  • NVRI 601.7K
  • STOK 585.1K
  • Earning Date
  • NVRI 07-31-2025
  • STOK 08-06-2025
  • Dividend Yield
  • NVRI N/A
  • STOK N/A
  • EPS Growth
  • NVRI N/A
  • STOK N/A
  • EPS
  • NVRI N/A
  • STOK 0.88
  • Revenue
  • NVRI $2,290,612,000.00
  • STOK $190,908,000.00
  • Revenue This Year
  • NVRI $0.02
  • STOK $378.84
  • Revenue Next Year
  • NVRI $3.71
  • STOK N/A
  • P/E Ratio
  • NVRI N/A
  • STOK $13.00
  • Revenue Growth
  • NVRI N/A
  • STOK 2333.81
  • 52 Week Low
  • NVRI $4.72
  • STOK $5.35
  • 52 Week High
  • NVRI $12.79
  • STOK $16.15
  • Technical
  • Relative Strength Index (RSI)
  • NVRI 68.31
  • STOK 63.94
  • Support Level
  • NVRI $8.34
  • STOK $11.17
  • Resistance Level
  • NVRI $8.62
  • STOK $12.14
  • Average True Range (ATR)
  • NVRI 0.23
  • STOK 0.51
  • MACD
  • NVRI -0.03
  • STOK -0.05
  • Stochastic Oscillator
  • NVRI 99.12
  • STOK 54.07

About NVRI Enviri Corporation

Enviri Corp is a market-leading, provider of environmental solutions for industrial and specialty waste streams, and equipment and technology for the rail sector. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company gains its revenue from Harsco Environmental segment. Geographically company operates in USA and International Countries, with majority revenue from USA.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: